517 related articles for article (PubMed ID: 26150697)
1. Sphingosine kinase 1 as an anticancer therapeutic target.
Gao Y; Gao F; Chen K; Tian ML; Zhao DL
Drug Des Devel Ther; 2015; 9():3239-45. PubMed ID: 26150697
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
3. New perspectives on the role of sphingosine 1-phosphate in cancer.
Pyne S; Pyne NJ
Handb Exp Pharmacol; 2013; (216):55-71. PubMed ID: 23563651
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate signalling in cancer.
Pyne NJ; Tonelli F; Lim KG; Long JS; Edwards J; Pyne S
Biochem Soc Trans; 2012 Feb; 40(1):94-100. PubMed ID: 22260672
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine kinase 1 in cancer.
Heffernan-Stroud LA; Obeid LM
Adv Cancer Res; 2013; 117():201-35. PubMed ID: 23290781
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of targeting SK1 in human cancers.
Alshaker H; Sauer L; Monteil D; Ottaviani S; Srivats S; Böhler T; Pchejetski D
Adv Cancer Res; 2013; 117():143-200. PubMed ID: 23290780
[TBL] [Abstract][Full Text] [Related]
7. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
8. The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.
Wang X; Sun Y; Peng X; Naqvi SMAS; Yang Y; Zhang J; Chen M; Chen Y; Chen H; Yan H; Wei G; Hong P; Lu Y
Cancer Control; 2020; 27(1):1073274820976664. PubMed ID: 33317322
[TBL] [Abstract][Full Text] [Related]
9. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis.
Ponnusamy S; Selvam SP; Mehrotra S; Kawamori T; Snider AJ; Obeid LM; Shao Y; Sabbadini R; Ogretmen B
EMBO Mol Med; 2012 Aug; 4(8):761-75. PubMed ID: 22707406
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine kinase as a regulator of calcium entry through autocrine sphingosine 1-phosphate signaling in thyroid FRTL-5 cells.
Gratschev D; Löf C; Heikkilä J; Björkbom A; Sukumaran P; Hinkkanen A; Slotte JP; Törnquist K
Endocrinology; 2009 Nov; 150(11):5125-34. PubMed ID: 19797403
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis.
Yang L; Yue S; Yang L; Liu X; Han Z; Zhang Y; Li L
J Hepatol; 2013 Jul; 59(1):114-23. PubMed ID: 23466305
[TBL] [Abstract][Full Text] [Related]
12. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors.
Orr Gandy KA; Obeid LM
Biochim Biophys Acta; 2013 Jan; 1831(1):157-66. PubMed ID: 22801037
[TBL] [Abstract][Full Text] [Related]
13. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.
Schwalm S; Pfeilschifter J; Huwiler A
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):44-9. PubMed ID: 23789924
[TBL] [Abstract][Full Text] [Related]
14. Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Pyne NJ; McNaughton M; Boomkamp S; MacRitchie N; Evangelisti C; Martelli AM; Jiang HR; Ubhi S; Pyne S
Adv Biol Regul; 2016 Jan; 60():151-159. PubMed ID: 26429117
[TBL] [Abstract][Full Text] [Related]
15. [The drug development based on sphingosine-1-phosphate signaling pathway].
Bai J; Hu JP
Yao Xue Xue Bao; 2016 Dec; 51(12):1822-8. PubMed ID: 29908533
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.
Schnitzer SE; Weigert A; Zhou J; Brüne B
Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180
[TBL] [Abstract][Full Text] [Related]
17. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
Huwiler A; Pfeilschifter J
Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells.
El-Shewy HM; Sohn M; Wilson P; Lee MH; Hammad SM; Luttrell LM; Jaffa AA
Mol Endocrinol; 2012 May; 26(5):833-45. PubMed ID: 22422617
[TBL] [Abstract][Full Text] [Related]
19. Involvement of released sphingosine 1-phosphate/sphingosine 1-phosphate receptor axis in skeletal muscle atrophy.
Pierucci F; Frati A; Battistini C; Matteini F; Iachini MC; Vestri A; Penna F; Costelli P; Meacci E
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3598-3614. PubMed ID: 30279138
[TBL] [Abstract][Full Text] [Related]
20. Targeting sphingosine-1-phosphate signaling in lung diseases.
Ebenezer DL; Fu P; Natarajan V
Pharmacol Ther; 2016 Dec; 168():143-157. PubMed ID: 27621206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
